Core Viewpoint - The company announced a cash dividend distribution of 0.30 yuan per share (including tax) for the first three quarters of 2025, approved at the third extraordinary general meeting of shareholders on November 7, 2025 [2][3]. Summary by Sections Dividend Distribution Plan - The profit distribution plan is based on the total share capital minus the shares held in the company's repurchase account, with a proposed distribution of 3.00 yuan for every 10 shares held [3][4]. - The total number of shares eligible for the dividend is 97,807,857, leading to a total cash dividend payout of approximately 29,342,357.10 yuan (including tax) [3]. Implementation Details - The cash dividends will be distributed through the China Securities Depository and Clearing Corporation Limited Shanghai Branch, with specific arrangements for shareholders who have not completed designated transactions [6][8]. - Shares held in the repurchase account will not participate in the profit distribution [7]. Taxation Information - For individual shareholders holding unrestricted shares, dividends are subject to different tax treatments based on the holding period, with a maximum tax rate of 20% for shares held for less than one month [9][11]. - For qualified foreign institutional investors (QFII), a 10% withholding tax will apply, resulting in a net cash dividend of 0.27 yuan per share after tax [11][12]. - Other institutional investors will be responsible for their own tax payments, with the gross cash dividend being 0.30 yuan per share [12].
南京麦澜德医疗科技股份有限公司2025年前三季度权益分派实施公告